The stock has 3 chances to rebound in the next few months:
1. BTX 1503 Investigation Result. (not likely to be available although, but if result points to manufacturing errors, could rebound to 0.15)
2. BTX 1503 Stage 3 Clinical Trial FDA Green Light. (Likely to back to 0.15 to 0.18 if happens)
3. BTX 1204 Stage 2 Trial Result. (significant north)
Be patient.
Ann: Botanix Announces De-scheduling of Synthetic CBD, page-85
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 31.5¢ | $1.940M | 6.061M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 470483 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 33000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |